drugset / Trial / NCT00063193
National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial
Phase 2
Completed
195 enrolled
University of Rochester
National Institute of Neurological Disorders and Stroke (NINDS) · collab
RandomizedDouble-blindTreatment
Summary
The goal of this study is to assess the impact of minocycline and creatine on the progression of Parkinson's disease, in order to determine whether it is reasonable to proceed with further study of either of these agents.
Timeline
- Start
- 2003-05
- Primary completion
- 2005-05
- Completion
- 2005-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Creatine | Other / unclassified | — | — |
| Subject | Minocycline | Small molecule | — | — |